MoneyWorks4Me

Abbott India to stop selling Xience Alpine drug-eluting stent in India

26 Apr 2018 Evaluate

Abbott India has done with all the necessary formalities to stop selling its Xience Alpine drug-eluting stent in India. Hence, the company will not be selling the device in the country from April 26, 2018.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..